tiprankstipranks
Advertisement
Advertisement
Nexalin announces continued advancement toward trial evaluating HALO Clarity
PremiumThe FlyNexalin announces continued advancement toward trial evaluating HALO Clarity
2M ago
Nexalin announces continued advancement toward trial evaluating HALO Clarity
Premium
The Fly
Nexalin announces continued advancement toward trial evaluating HALO Clarity
2M ago
Nexalin ‘commended’ recent Congressional initiative on neurostim research
Premium
The Fly
Nexalin ‘commended’ recent Congressional initiative on neurostim research
3M ago
Nexalin Technology Unveils New Investor Presentation on DIFS
PremiumCompany AnnouncementsNexalin Technology Unveils New Investor Presentation on DIFS
5M ago
Nexalin Technology completes FDA Q-sub meeting for Gen-2 SYNC neurostimulation
Premium
The Fly
Nexalin Technology completes FDA Q-sub meeting for Gen-2 SYNC neurostimulation
5M ago
Nexalin announces results for 15 mA neurostimulation device
Premium
The Fly
Nexalin announces results for 15 mA neurostimulation device
6M ago
Nexalin announces three studies published on Gen-2 Nexalin DIFS technology
PremiumThe FlyNexalin announces three studies published on Gen-2 Nexalin DIFS technology
7M ago
Nexalin Technology Amends Equity Distribution Agreement
Premium
Company Announcements
Nexalin Technology Amends Equity Distribution Agreement
7M ago
Nexalin Technology appoints Robert Rothstein to Scientific Advisory Board
Premium
The Fly
Nexalin Technology appoints Robert Rothstein to Scientific Advisory Board
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100